JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 9, 2005; DOI: 10.1124/jpet.105.085928


0022-3565/05/3143-1353-1361$20.00
JPET 314:1353-1361, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.085928v1
314/3/1353    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanjhan, R.
Right arrow Articles by Bellingham, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanjhan, R.
Right arrow Articles by Bellingham, M. C.

NEUROPHARMACOLOGY

Tertiapin-Q Blocks Recombinant and Native Large Conductance K+ Channels in a Use-Dependent Manner

Refik Kanjhan, Elizabeth J. Coulson, David J. Adams, and Mark C. Bellingham

School of Biomedical Sciences (R.K., E.J.C., D.J.A., M.C.B.) and The Queensland Brain Institute (E.J.C.), University of Queensland, Brisbane, Australia

Tertiapin, a short peptide from honey bee venom, has been reported to specifically block the inwardly rectifying K+ (Kir) channels, including G protein-coupled inwardly rectifying potassium channel (GIRK) 1+GIRK4 heteromultimers and ROMK1 homomultimers. In the present study, the effects of a stable and functionally similar derivative of tertiapin, tertiapin-Q, were examined on recombinant human voltage-dependent Ca2+-activated large conductance K+ channel (BK or MaxiK; {alpha}-subunit or hSlo1 homomultimers) and mouse inwardly rectifying GIRK1+GIRK2 (i.e., Kir3.1 and Kir3.2) heteromultimeric K+ channels expressed in Xenopus oocytes and in cultured newborn mouse dorsal root ganglion (DRG) neurons. In two-electrode voltage-clamped oocytes, tertiapin-Q (1-100 nM) inhibited BK-type K+ channels in a use- and concentration-dependent manner. We also confirmed the inhibition of recombinant GIRK1+GIRK2 heteromultimers by tertiapin-Q, which had no effect on endogenous depolarization- and hyperpolarization-activated currents sensitive to extracellular divalent cations (Ca2+, Mg2+, Zn2+, and Ba2+) in defolliculated oocytes. In voltage-clamped DRG neurons, tertiapin-Q voltage- and use-dependently inhibited outwardly rectifying K+ currents, but Cs+-blocked hyperpolarization-activated inward currents including IH were insensitive to tertiapin-Q, baclofen, barium, and zinc, suggesting absence of functional GIRK channels in the newborn. Under current-clamp conditions, tertiapin-Q blocked the action potential after hyperpolarization (AHP) and increased action potential duration in DRG neurons. Taken together, these results demonstrate that the blocking actions of tertiapin-Q are not specific to Kir channels and that the blockade of recombinant BK channels and native neuronal AHP currents is use-dependent. Inhibition of specific types of Kir and voltage-dependent Ca2+-activated K+ channels by tertiapin-Q at nanomolar range via different mechanisms may have implications in pain physiology and therapy.


Received March 7, 2005; accepted June 2, 2005.

Address correspondence to: Dr. Refik Kanjhan, School of Biomedical Sciences, University of Queensland, St. Lucia 4072 Queensland, Australia. E-mail: r.kanjhan{at}uq.edu.au




This article has been cited by other articles:


Home page
J Clin PharmacolHome page
B. F. McBride
The Emerging Role of Antiarrhythmic Compounds With Atrial Selectivity in the Management of Atrial Fibrillation
J. Clin. Pharmacol., March 1, 2009; 49(3): 258 - 267.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Klose, T. Huth, and C. Alzheimer

Mol. Pharmacol., November 1, 2008; 74(5): 1203 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. M. Troncoso Brindeiro, R. W. Fallet, P. H. Lane, and P. K. Carmines
Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F171 - F178.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
C. P. Bolter and D. J. English
The effects of tertiapin-Q on responses of the sinoatrial pacemaker of the guinea-pig heart to vagal nerve stimulation and muscarinic agonists
Exp Physiol, January 1, 2008; 93(1): 53 - 63.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. A. Smith, K. Hisadome, H. Al-Qassab, H. Heffron, D. J. Withers, and M. L. J. Ashford
Melanocortins and agouti-related protein modulate the excitability of two arcuate nucleus neuron populations by alteration of resting potassium conductances
J. Physiol., January 15, 2007; 578(2): 425 - 438.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
T. K. Best, R. J. Siarey, and Z. Galdzicki
Ts65Dn, a Mouse Model of Down Syndrome, Exhibits Increased GABAB-Induced Potassium Current
J Neurophysiol, January 1, 2007; 97(1): 892 - 900.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Wieland and S. Herzig
Specificity and Diversity in Gi/o-Mediated Signaling: How the Heart Operates the RGS Brake Pedal
Circ. Res., March 17, 2006; 98(5): 585 - 586.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.